A review of erlotinib and its clinical use
PA Tang, MS Tsao, MJ Moore - Expert opinion on pharmacotherapy, 2006 - Taylor & Francis
Erlotinib is an orally available, reversible tyrosine kinase inhibitor of the epidermal growth
factor receptor. Encouraging activity as a single agent and in combination with other …
factor receptor. Encouraging activity as a single agent and in combination with other …
[引用][C] A review of erlotinib and its clinical use
T PA - Expert Opin Pharmacother, 2006 - cir.nii.ac.jp
A review of erlotinib and its clinical use.
PA Tang, MS Tsao, MJ Moore - Expert Opinion on Pharmacotherapy, 2006 - europepmc.org
Erlotinib is an orally available, reversible tyrosine kinase inhibitor of the epidermal growth
factor receptor. Encouraging activity as a single agent and in combination with other …
factor receptor. Encouraging activity as a single agent and in combination with other …
A review of erlotinib and its clinical use
PA Tang, MS Tsao, MJ Moore - Expert opinion on …, 2006 - pubmed.ncbi.nlm.nih.gov
Erlotinib is an orally available, reversible tyrosine kinase inhibitor of the epidermal growth
factor receptor. Encouraging activity as a single agent and in combination with other …
factor receptor. Encouraging activity as a single agent and in combination with other …